|

IPH5201 + durvalumab + standard chemotherapy Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Carboplatin/Paclitaxel Carboplatin/Paclitaxel, as chemotherapy, Durvalumab, MEDI4736, IMFINZI, Pemetrexed/Carboplatin Pemetrexed/Carboplatin as chemotherapy, Pemetrexed/Cisplatin Pemetrexed/Cisplatin as chemotherapy

Pipeline

Phase 2: 1

Top Sponsors

  • Innate Pharma1

Indications

  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

St. Petersburg, Florida1 trial

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

St. Anthony's Hospital - BayCare Health System

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.